Formation of Hydroxyapatite-Based Hybrid Materials in the Presence of Platelet-Poor Plasma Additive

被引:2
作者
Glazov, Ilya E. E. [1 ]
Krutko, Valentina K. K. [1 ]
Safronova, Tatiana V. V. [2 ,3 ]
Sazhnev, Nikita A. A. [4 ]
Kildeeva, Natalia R. R. [4 ]
Vlasov, Roman A. A. [5 ]
Musskaya, Olga N. N. [1 ]
Kulak, Anatoly I. I. [1 ]
机构
[1] Natl Acad Sci Belarus, Inst Gen & Inorgan Chem, Surganova Str 9-1, Minsk 220012, BELARUS
[2] Lomonosov Moscow State Univ, Dept Chem, Bldg 3,Leninskie Gory 1, Moscow 119991, Russia
[3] Lomonosov Moscow State Univ, Dept Mat Sci, Bldg 73,Leninskie Gory 1, Moscow 119991, Russia
[4] Kosygin Russian State Univ, Dept Chem & Technol Polymer Mat & Nanocomposites, Malaya Kaluzhskaya 1, Moscow 119071, Russia
[5] Med Ctr Lode, Gikalo Str 1, Minsk 220005, BELARUS
关键词
hybrid material; hydroxyapatite formation; amorphous calcium phosphate; platelet-poor plasma; solubility; SBF; CALCIUM; FIBRIN; PRP;
D O I
10.3390/biomimetics8030297
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Biomaterials based on hydroxyapatite with controllable composition and properties are promising in the field of regenerative bone replacement. One approach to regulate the phase composition of the materials is the introduction of biopolymer-based additives into the synthesis process. The purpose of present study was to investigate the formation of hydroxyapatite-based hybrid materials in the presence of 6-24% platelet-poor plasma (PPP) additive, at a [Ca2+]/[PO43-] ratio of 1.67, pH 11, and varying maturing time from 4 to 9 days. The mineral component of the materials comprised 53% hydroxyapatite/47% amorphous calcium phosphate after 4 days of maturation and 100% hydroxyapatite after 9 days of maturation. Varying the PPP content between 6% and 24% brought about the formation of materials with rather defined contents of amorphous calcium phosphate and biopolymer component and the desired morphology, ranging from typical apatitic conglomerates to hybrid apatite-biopolymer fibers. The co-precipitated hybrid materials based on hydroxyapatite, amorphous calcium phosphate, and PPP additive exhibited increased solubility in SBF solution, which defines their applicability for repairing rhinoplastic defects.
引用
收藏
页数:12
相关论文
共 38 条
  • [21] A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer
    Iversen, Line V.
    Ostergaard, Ole
    Nielsen, Christoffer T.
    Jacobsen, Soren
    Heegaard, Niels H. H.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2013, 388 (1-2) : 49 - 59
  • [22] Platelet-poor plasma-based biofiller: An innovative alternative to expensive hyaluronic acidebased fillers for treatment of chicken pox scars
    Dashore, Shuken
    Dashore, Anil
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (01) : E11 - E13
  • [23] EVALUATION OF POSTOPERATIVE DRAINAGE WITH APPLICATION OF PLATELET-RICH AND PLATELET-POOR PLASMA FOLLOWING HEMITHYROIDECTOMY: A RANDOMIZED CONTROLLED CLINICAL TRIAL
    Yoo, John
    Roth, Kathryn
    Hughes, Brian
    Fung, Kevin
    Franklin, Jason
    Lampe, Howard
    Pietrzak, William S.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (12): : 1552 - 1558
  • [24] The use of adipose- derived stem cells, plateletrich and platelet-poor plasma in the maxillary cyst treatment
    Simoncic, Boris
    Dimitrijevic, Maja
    Juloski, Jelena
    Vulicevic, Zoran R.
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (9-10) : 589 - 593
  • [25] Histomorphometric analysis of rabbit calvarial bone: Storage in saline solution versus storage in platelet-poor plasma
    Dechichi, Paula
    Moura, Camilla Christian Gomes
    Santana, Sandro Izairas
    Zanetta-Barbosa, Darceny
    INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2007, 22 (06) : 905 - 910
  • [26] Platelet-Rich Plasma Versus Platelet-Poor Plasma for Treating Facial Photoaging: a Double-Blind Randomized Controlled Splitting Face Study
    Tsai, Ya-Wen
    Cheng, Chun-Yu
    Hu, Sindy
    Chang, Shyue-Luen
    Lin, Tsai-Ming
    Huang, Yau-Li
    AESTHETIC PLASTIC SURGERY, 2024, 48 (11) : 2162 - 2170
  • [27] Expression of microRNAs in human platelet-poor plasma: analysis of the factors affecting their expression and association with proximal genetic variants
    Rodriguez-Rius, Alba
    Martinez-Perez, Angel
    Lopez, Sonia
    Sabater-Lleal, Maria
    Carlos Souto, Juan
    Manuel Soria, Jose
    EPIGENETICS, 2020, 15 (12) : 1396 - 1406
  • [28] Platelet-Rich and Platelet-Poor Plasma Might Play Supportive Roles in Cancer Cell Culture: A Replacement for Fetal Bovine Serum?
    Talebi, Mehdi
    Vatanmakanian, Mousa
    Mirzaei, Ali
    Barfar, Yaghoub
    Hemmatzadeh, Maryam
    Nahayati, Milad A.
    Velaei, Kobra
    Hosseinzadeh, Asghar
    Yazdanpanah, Behruz
    Yahyavi, Yahya
    Azimi, Ako
    Rahmani, Mina
    Heydarabad, Milad Z.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (16) : 2236 - 2242
  • [29] Use of Platelet-Poor Plasma in Acute Quadriceps Muscle Strain in a Division I Football Placekicker: A Case Report
    Kasitinon, Donald
    Dragoo, Jason L.
    Hwang, Calvin E.
    CURRENT SPORTS MEDICINE REPORTS, 2021, 20 (11) : 572 - 574
  • [30] Comparable efficacy of platelet-rich plasma against platelet-poor plasma in stable vitiligo on concurrent psoralen+sunlight therapy: a hospital-based open-labeled study
    Agarwal, Neni
    Gahalaut, Pratik
    Mishra, Nitin
    Rastogi, Madhur Kant
    Mehra, Mriganka
    Varshney, Ajitesh P.
    JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY, 2021, 18 (01): : 35 - 42